StockData
Adaptimmune Therapeutics PLC logo

Adaptimmune Therapeutics PLC (ADAPY) stock

ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2025, quarter ended Jun 30, 2025Last filing: 10-Q on Aug 13, 2025Score 3/30
$0.04+0.00 (+9.38%)

Close on Oct 19, 2026Market cap $55.46MP/E –Yield –

Adaptimmune Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Adaptimmune Therapeutics's market cap was $55.66M on Oct 19, 2026, against $79.83M a year earlier. Over the last 5 years it ranged from $9.70M to $3.89B, with a median of $1.05B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$55.66M+34.6%
2025Dec 31, 2025$41.35M-95.0%
2024Dec 31, 2024$826.94M-23.4%
2023Dec 29, 2023$1.08B-24.7%
2022Dec 30, 2022$1.43B-59.2%
2021Dec 31, 2021$3.51B-29.8%
2020Dec 31, 2020$5.00B+561.0%
2019Dec 31, 2019$757.14M-79.0%
2018Dec 31, 2018$3.61B-4.0%
2017Dec 29, 2017$3.75B+118.3%
2016Dec 30, 2016$1.72B-66.4%
2015Dec 31, 2015$5.12B–

More Adaptimmune Therapeutics figures

See a number that looks wrong?